• News
  • SAN DIEGO
  • Health

Neurocrine Biosciences granted two patents

Neurocrine Biosciences Inc. (Nasdaq: NBIX) has announced that two more patents have been granted related to the company's proprietary Vesicular Monoamine Transporter 2 inhibitor.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Neurocrine Biosciences Inc.

Company Website

12790 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
NBIX
47.05
  0.67  
+ 1.44%
930,126,000
56.18
15.1

Insider Trade Data

Date Insider Shares Type Value
07/13/2015 Coughlin, Timothy P 20,000 Sell $1,000,000
07/13/2015 Coughlin, Timothy P 20,000 Exchange $115,200
07/13/2015 Grigoriadis, Dimitri E 10,000 Sell $500,000
07/13/2015 Grigoriadis, Dimitri E 10,000 Exchange $57,600
07/13/2015 O Brien, Christopher F 10,000 Sell $500,000

Neurocrine Biosciences Inc. Executive(s):

Kevin Gorman

  • Chief Executive Officer, President

Similar Companies

NAICS - 541711 - Research and Development in Biotechnology
Subscribe Today!